MMP-2, mouse
- Known as:
- MMP-2, mouse
- Catalog number:
- 7780-5
- Product Quantity:
- 5 μg
- Category:
- -
- Supplier:
- Biovis
- Gene target:
- MMP-2 mouse
Related genes to: MMP-2, mouse
- Gene:
- IMMP2L NIH gene
- Name:
- inner mitochondrial membrane peptidase subunit 2
- Previous symbol:
- IMMP2L-IT1
- Synonyms:
- IMP2
- Chromosome:
- 7q31.1
- Locus Type:
- gene with protein product
- Date approved:
- 2003-07-11
- Date modifiied:
- 2018-01-23
- Gene:
- MMP2 NIH gene
- Name:
- matrix metallopeptidase 2
- Previous symbol:
- CLG4, CLG4A
- Synonyms:
- TBE-1
- Chromosome:
- 16q12.2
- Locus Type:
- gene with protein product
- Date approved:
- 1989-05-25
- Date modifiied:
- 2015-02-23
- Gene:
- MMP15 NIH gene
- Name:
- matrix metallopeptidase 15
- Previous symbol:
- -
- Synonyms:
- MT2-MMP, MTMMP2, SMCP-2
- Chromosome:
- 16q21
- Locus Type:
- gene with protein product
- Date approved:
- 1996-11-13
- Date modifiied:
- 2016-10-05
- Gene:
- MMP23A NIH gene
- Name:
- matrix metallopeptidase 23A (pseudogene)
- Previous symbol:
- MMP21
- Synonyms:
- MIFR
- Chromosome:
- 1p36.33
- Locus Type:
- pseudogene
- Date approved:
- 1999-08-26
- Date modifiied:
- 2016-10-05
- Gene:
- MMP23B NIH gene
- Name:
- matrix metallopeptidase 23B
- Previous symbol:
- MMP22
- Synonyms:
- MIFR, MIFR-1
- Chromosome:
- 1p36.33
- Locus Type:
- gene with protein product
- Date approved:
- 1999-08-26
- Date modifiied:
- 2016-10-05
Related products to: MMP-2, mouse
Related articles to: MMP-2, mouse
- Pancreatic cancer (PC) remains a lethal malignancy with limited treatment options. The role of innate immune cell barrier-related genes in PC prognosis is poorly defined. This study aimed to identify prognostic biomarkers, develop a predictive model, and uncover novel targets for personalized therapy. - Source: PubMed
Publication date: 2025/05/23
Luo QiangJiang TingtingXie DachengLi XiaojiaXie Keping - To explore the relationship between matrix metalloproteinases (MMPs) expression levels in the tumor and the prognosis of uveal melanoma (UM) and to construct prognostic prediction models. - Source: PubMed
Publication date: 2025/05/18
Chen Yu-NingXiu Jing-YingZhao Han-QingLuo Jing-TingYang QiongLi YangWei Wen-Bin - Sustaining proliferation signaling is the top hallmarks of cancer, driving continuous tumor growth and resistance to drug treatments. Blocking proliferation signaling has shown limited benefit in clinical treatment of pancreatic ductal adenocarcinoma, highlighting the urgent need to deeply understand proliferation signaling and develop new therapeutic strategies. - Source: PubMed
Publication date: 2025/02/24
Hong ZhengtaoHuang XingXia LinghaoLiang TingboBai Xueli - Crosstalk between pancreatic cancer cells and tumor-associated macrophages (TAMs) is a critical driver of malignant progression, and plays an important role in the low response rate to immunotherapy in patients with for pancreatic cancer. Although it is known that cancer cells induce TAM infiltration and M2 polarization, the underlying mechanisms remain elusive. Herein, we identified matrix metalloproteinase 28 (MMP28), a highly expressed protein, as a key regulator of this process. - Source: PubMed
Publication date: 2025/02/19
Dong ShiLi XinChen ZhouShi HuaqingWang ZhengfengZhou Wence - Although recent progress provides mechanistic insights into diabetic nephropathy (DN), effective treatments remain scarce. DN, characterized by proteinuria and a progressive decline in renal function, primarily arises from podocyte injury, which impairs the glomerular filtration barrier. Wogonoside, a bioactive compound from the traditional Chinese herb Scutellaria baicalensis, has not been explored for its role in DN. - Source: PubMed
Publication date: 2025/01/24
Li XiandengZhao ShuyanXie JingLi MiTong ShuangmeiMa JingYang RuiZhao QinjianZhang JianXu Ajing